Literature DB >> 16482732

An integrative approach to addressing clinical issues in complementary and alternative medicine in an outpatient oncology center.

Ooi-Thye Chong1.   

Abstract

Complementary and alternative medicine (CAM) is popular among patients with cancer and often is used in conjunction with conventional medicine, mostly without the knowledge or guidance of healthcare professionals. The popularity of CAM has brought into sharp focus clinical issues such as the lack of disclosure and concern about interactions among dietary supplements, prescribed medications, and diseases. Those clinical issues underscore the need for a coordinated approach to integrate CAM therapies safely into conventional medicine. This article describes how an integrative CAM program in an outpatient oncology center addresses some of the clinical issues. The CAM program uses a nurse specialist to interface between CAM and conventional medicine. An interesting aspect of the CAM program is the provision of patient consultation and the creation of an individualized complementary therapies plan.

Entities:  

Mesh:

Year:  2006        PMID: 16482732     DOI: 10.1188/06.CJON.83-88

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN: 1092-1095            Impact factor:   1.027


  7 in total

1.  A systematic review of integrative oncology programs.

Authors:  D M Seely; L C Weeks; S Young
Journal:  Curr Oncol       Date:  2012-12       Impact factor: 3.677

Review 2.  Addressing Complementary and Alternative Medicine Use Among Individuals With Cancer: An Integrative Review and Clinical Practice Guideline.

Authors:  Lynda G Balneaves; Cody Z Watling; Emilie N Hayward; Brenda Ross; Jill Taylor-Brown; Antony Porcino; Tracy L O Truant
Journal:  J Natl Cancer Inst       Date:  2022-01-11       Impact factor: 13.506

3.  A complex nursing intervention of complementary and alternative medicine (CAM) to increase quality of life in patients with breast and gynecologic cancer undergoing chemotherapy: study protocol for a partially randomized patient preference trial.

Authors:  Nadja Klafke; Cornelia Mahler; Cornelia von Hagens; Justine Rochon; Andreas Schneeweiss; Andreas Müller; Hans-Joachim Salize; Stefanie Joos
Journal:  Trials       Date:  2015-02-15       Impact factor: 2.279

4.  Impact of Open Dialogue about Complementary Alternative Medicine-A Phase II Randomized Controlled Trial.

Authors:  Mette Stie; Charlotte Delmar; Birgitte Nørgaard; Lars Henrik Jensen
Journal:  Cancers (Basel)       Date:  2022-02-14       Impact factor: 6.575

5.  Efficacy of open dialogue about complementary and alternative medicine compared with standard care in improving quality of life in patients undergoing conventional oncology treatment (CAMONCO 2): protocol for a randomised controlled trial.

Authors:  Mette Stie; Charlotte Delmar; Birgitte Nørgaard; Lars Henrik Jensen
Journal:  BMJ Open       Date:  2022-04-25       Impact factor: 3.006

6.  Patient Disclosure about Herb and Supplement Use among Adults in the US.

Authors:  Jae Kennedy; Chi-Chuan Wang; Chung-Hsuen Wu
Journal:  Evid Based Complement Alternat Med       Date:  2007-05-17       Impact factor: 2.629

Review 7.  Decision-making about complementary and alternative medicine by cancer patients: integrative literature review.

Authors:  Laura Weeks; Lynda G Balneaves; Charlotte Paterson; Marja Verhoef
Journal:  Open Med       Date:  2014-04-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.